KATHLEEN MCLEOD: Open Payments
NPI 1720054992 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,769 in 78 payments from 22 companies in 2025. Trend: 2023 $1,638 · 2024 $1,488 · 2025 $1,769
Food & beverage: $1,769
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $245 |
| AstraZeneca Pharmaceuticals LP | 8 | $194 |
| Novartis Pharmaceuticals Corporation | 12 | $181 |
| Amgen Inc. | 13 | $164 |
| Lundbeck LLC | 3 | $164 |
| ABBVIE INC. | 7 | $142 |
| PFIZER INC. | 1 | $117 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Phathom Pharmaceuticals, Inc. | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
Products named: KISUNLA, LEQVIO, VYEPTI, ZAVZPRET, BREZTRI, EVENITY, OTEZLA, VOQUEZNA.
Industry payments across AZ — which companies pay providers there.
